Proteome profiling of aging in mouse models: Differential expression of proteins involved in metabolism, transport, and stress response in kidney

Proteomics

Volumn 9, Issue 3, 2009, Pages 580-597

  Chakravarti, Bulbul ^a   Seshi, Beerelli ^b   Ratanaprayul, Wongrat ^a   Dalal, Neville ^a   Lin, Lawrence ^a   Raval, Alpan ^c   Chakravarti, Deb N ^a  

^a KECK GRADUATE INSTITUTE   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c CLAREMONT GRADUATE UNIVERSITY   (United States)

Author keywords

Aging; Mouse kidney; Proteomics

Indexed keywords

ALDEHYDE DEHYDROGENASE; CHAPERONE; FUMARATE HYDRATASE; HIGH DENSITY LIPOPROTEIN; PROTEOME; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SELENIUM BINDING PROTEIN; TRANSFERRIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; KIDNEY METABOLISM; KIDNEY TUBULE ABSORPTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS;

AGING; ANIMALS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; KIDNEY; MALE; MICE; MICE, INBRED C57BL; PROTEOME; TANDEM MASS SPECTROMETRY;

MUS;

EID: 60549096680     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700208     Document Type: Article

References (57)

1. Lindeman, R. D., Tobin, J. D., Shock, N. W., Relation between blood pressure and the rate of decline in renal function with age. Kidney Int. 1984, 26, 861-868.
2. Kasiske, B. L., Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int. 1987, 31, 1153-1159.
3. Fliser, D., Franek, E., Joest, M., Block, S. et al., Renal function in the elderly: Impact of hypertension and cardiac function. Kidney Int. 1997, 51, 1196-1204.
4. Bleyer, A. J., Shemanski, L. R., Burke, G. L., Hansen, K. J. et al., Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population. Kidney Int. 2000, 57, 2072-2079.
5. Ribstein, J., Du Cailar, G., Mimran, A., Glucose tolerance and age-associated decline in renal function of hypertensive patients. J. Hypertens. 2001, 19, 2257-2264.
6. Nyengaard, J. R., Bendtsen, T. F., Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat. Rec. 1992, 232, 194-201.
7. Takeda, T., Imada, A., Horiuchi, A., Kimura, M. et al., Age-related changes in morphological studies in rat and human kidney. Nippon Jinzo Gakkai Shi 1996, 38, 555-562.
8. Lubran, M. M., Renal function in the elderly. Ann. Clin. Lab. Sci. 1995, 25, 122-133.
9. Wharton, W. W., Sondeen, J. L., McBiles, M., Gradwohl, S. E. et al., Measurement of glomerular filtration rate in ICU patients using 99mTc-DTPA and inulin. Kidney Int. 1992, 42, 174-178.
10. Goldstein, R. S., Tarloff, J. B., Hook, J. B., Age-related nephropathy in laboratory rats. FASEB J. 1988, 2,2241-2251.
11. Baylis, C., Fredericks, M., Leypoldt, J., Frigon, R. et al., The mechanisms of proteinuria in aging rats. Mech. Ageing Dev. 1988, 45, 111-126.
12. Ihaka, R., Gentleman, R. R., A language for data analysis and graphics. J. Comput. Graph. Stat. 1996, 5, 299-314.
13. Chakravarti, B., Oseguera, M., Dalal, N., Fathy, P. et al., Proteome profiling of aging in the mouse heart: Altered expression of mitochondrial proteins. Arch. Biochem. Biophys. 2008, 474, 22-31.
14. Chakravarti, B., Ratanaprayul, W., Dalal, N., Chakravarti, D. N., Comparison of SYPRO ruby and deep purple using commonly available UV transilluminator: Wide-scale application in proteomic research. J. Proteome Res. 2008, 7, 2797-2802.
15. Kim, C. H., Park, D. U., Chung, A. S., Zou, Y. et al., Proteomic analysis of post-mitochondrial fractions of young and old rat kidney. Exp. Gerontol. 2004, 39, 1155-1168.
16. Schalkwijk, C. G., Ligtvoet, N., Twaalfhoven, H., Jager, A. et al., Amadori albumin in type 1 diabetic patients: Correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes 1999, 48, 2446-2453.
17. Schalkwijk, C. G., Chaturvedi, N., Twaafhoven, H., van Hinsbergh, V. W. et al., Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients. Eur. J. Clin. Invest. 2002, 32, 500-506.
18. Londono, I., Gingras, D., Bendayan, M., Circulating glycated albumin and glomerular anionic charges. Exp. Diabesity Res. 2003, 4, 83-92.
19. Cohen, M. P., Masson, N., Hud, E., Ziyadeh, F. et al., Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse. Exp. Nephrol. 2000, 8, 135-143.
20. Hattori, Y., Suzuki, M., Hattori, S., Kasai, K., Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hypertension 2002, 39, 22-28.
21. Chen, S., Cohen, M. P., Lautenslager, G. T., Shearman, C. W. et al., Glycated albumin stimulates TGF-beta 1 production and protein kinase C activity in glomerular endothelial cells. Kidney Int. 2001, 59, 673-681.
22. Chen, S., Cohen, M. P., Ziyadeh, F. N., Amadori-glycated albumin in diabetic nephropathy: Pathophysiologic connections. Kidney Int. Suppl. 2000, 77, S40-S44.
23. Bakala, H., Verbeke, P., Perichon, M., Corman, B. et al., Glycation of albumin with aging and diabetes in rats: Changes in its renal handling. Mech. Ageing Dev. 1995, 78, 63-71.
24. Monnier, V. M., Stevens, V. J., Cerami, A., Maillard reactions involving proteins and carbohydrates in vivo: Relevance to diabetes mellitus and aging. Prog. Food Nutr. Sci. 1981, 5, 315-327.
25. Jaleel, A., Halvatsiotis, P., Williamson, B., Juhasz, P. et al., Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment. Diabetes Care 2005, 28, 645-652.
26. Raj, D. S., Choudhury, D., Welbourne, T. C., Levi, M., Advanced glycation end products: A Nephrologist's perspective. Am. J. Kidney Dis. 2000, 35, 365-380.
27. Mene, P., Festuccia, F., Polci, R., Pugliese, F. et al., Diabetic nephropathy and advanced glycation end products. Contrib. Nephrol. 2001, 737, 22-32.
28. Yamagishi, S., Takeuchi, M., Makita, Z., Advanced glycation end products and the pathogenesis of diabetic nephropathy. Contrib. Nephrol. 2001, 734, 30-35.
29. Yan, L., Ge, H., Lieber, S. C., Natividad, F. et al., Gender-specific proteomic alterations in glycolytic and mitochondrial pathways in aging monkey hearts. J. Mol. Cell. Cardiol. 2004, 37, 921-929.
30. Poon, H. F., Vaishnav, R. A., Butterfield, D. A., Getchell, M. L. et al., Proteomic identification of differentially expressed proteins in the aging murine olfactory system and transcriptional analysis of the associated genes. J. Neurochem. 2005, 94, 380-392.
31. Chakravarti, B., Chakravarti, D. N., Oxidative modification of proteins: Age-related changes. Gerontology 2007, 53, 128-139.
32. Lesnefsky, E. J., Hoppel, C. L., Oxidative phosphorylation and aging. Ageing Res. Rev. 2006, 5, 402-433.
33. Yarian, C. S., Rebrin, I., Sohal, R. S., Aconitase and ATP synthase are targets of malondialdehyde modification and undergo an age-related decrease in activity in mouse heart mitochondria. Biochem. Biophys. Res. Commun. 2005, 330, 151-156.
34. Choksi, K., Nus, J. E., Boylston, W. H., Rabek, J. P. et al., Age-related increases inoxidatively damaged proteins of mouse kidney mitochondrial electron transport chain complexes. Free Radic. Biol. Med. 2007, 43, 1423-1438.
35. Alnouti, Y., Klaassen, C. D., Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice. Toxicol. Sci. 2008, 707, 51-64.
36. Vasiliou, V., Nebert, D. W., Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. Hum. Genomics 2005, 2, 138-143.
37. Jones, J. M., Morrell, J. C., Gould, S. J., Identification and characterization of HAOX1, HAOX2, and HAOX3, three human peroxisomal 2-hydroxy acid oxidases. J. Biol. Chem. 2000, 275, 12590-12597.
38. Wagner, C. A., Finberg, K. E., Breton, S., Marshansky, V. et al., Renal vacuolar H+-ATPase. Physiol. Rev. 2003, 84, 1263-1314.
39. Hall, A. M., Unwin, R. J., The not so 'mighty chondrion': Emergence of renal diseases due to mitochondrial dysfunction. Nephron. Physiol. 2007, 705, 1-10.
40. Tang, S., Leung, J. C. K., Tsang, A. W. L., Lan, H. Y. et al., Transferrin up-regulates chemokine synthesis by human proximal tubular epithelial cells. Implication on mechanism of tubuloglomerular communication in glomerulopathic proteinuria. Kidney Int. 2002, 67, 1655-1665.
41. Ellis, J., BiP is feed-back regulated by control of protein translation efficiency. Nature 1987, 328, 378-379.
42. Rabek, J. P, Boylston, W. H., Papaconstantinou, J., Carbonylation of ER chaperone proteins in aged mouse liver. Bio- chem. Biophys. Res. Commun. 2003, 305, 566-572.
43. Bu, G., The roles of receptor-associated protein (RAP) as a molecular chaperone for members of the LDL receptor family. Int. Rev. Cytol. 2001, 209, 79-116.
44. Ellgaard, L., Holtet,T. L., Nielsen, P. R., Etzerodt, M. et al., Dissection of the domain architecture of the alpha2macroglobulin-receptor- associated protein. Eur. J. Biochem. 1997, 244, 544-551. Erratum in: Eur. J. Biochem. 1997, 248, 947.
45. Kobayashi, T., Manno, A., Kakizuka, A., Involvement of valosin-containing protein (VCP)/p97 in the formation and clearance of abnormal protein aggregates. Genes Cells 2007, 72, 889-901.
46. Nonn, L., Berggren, M., Powis, G., Increased expression of mitochondrial peroxiredoxin-3 (Thioredoxin Peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol. Cancer Res. 2003, 7, 682-689.
47. Molin, M., Norbeck, J., Blomberg, A., Dihydroxyacetone kinases in Saccharomyces cerevisiae are involved in detoxification of dihydroxyacetone. J. Biol. Chem. 2003, 278, 1415-1423.
48. Bansal, M. P., Kaur, P., Selenium, a versatile trace element: Current research implications. Indian J. Exp. Biol. 2005, 43, 1119-1129.
49. Song, L., Zou, H., Chang, Y., Xu, W. et al., The cDNA cloning and mRNA expression of a potential selenium-binding protein gene in the scallop Chlamys farreri. Dev. Comp. Immunol. 2006, 30, 265-273.
50. Brown, K. M., Arthur, J. R., Selenium, selenoproteins and human health: A review. Public Health Nutr. 2001, 4, 593-599.
51. Jamba, L., Nehru, B., Bansal, M. P., Redox modulation of selenium binding proteins by cadmium exposures in mice. Mol. Cell. Biochem. 1997, 777, 169-175.
52. Porat, A., Sagiv, Y., Elazar, A., A 56-kDa Selenium-binding protein participates in intra-golgi protein transport. J. Biol. Chem. 2000, 275, 14457-14465.
53. Ishida, T., Tasaki, K., Fukuda, A., Ishii, Y. et al., Induction of a cytosolic 54 kDa protein in rat liver that is highly homologous to selenium-binding protein. Environ. Toxicol. Pharmacol. 1998, 6, 249-255.
54. Davies, I., Fotheringham, A. P., Faragher, B. E., Age-associated changes in the kidney of the laboratory mouse. Age Ageing 1989, 78, 127-133.
55. Percy, C. J., Power, D., Gobe, G. C., Renal ageing: Changes in the cellular mechanism of energy metabolism and oxidant handling. Nephrology 2008, 73, 147-152.
56. Lindeman, R. D., Overview: Renal physiology and pathophysiology of aging. Am. J. Kidney Dis. 1990, 76, 275-282.
57. Herring, K. D., Oppenheimer, S. R., Caprioli, R. M., Direct tissue analysis by matrix-assisted laser desorption ionization mass spectrometry: Application to kidney biology. Semin. Nephrol. 2007, 27, 597-608.